GL1X · GenesisL1 explorer

MolNFT v1 · #122747 · protein

Protruding domain of GII.4 human norovirus CHDC2094 in complex with 2- fucosyllactose (2'FL)

5IYR · GII.4 norovirus CHDC2094 capsid: “Protruding domain of GII.4 human norovirus CHDC2094 in complex with 2- fucosyllactose (2'FL)”. X-ray diffraction, 3 ligands (GLC, GAL, FUC), 7 pockets (best druggability 0.70). MolNFT v1 #122747 on…

PDB
5IYR
Type
protein
Length
609 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GII.4 norovirus CHDC2094 capsid
UniProt
D0QJ68
Ligands
GLC, GAL, FUC
Pockets
7 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGII.4 norovirus CHDC2094 capsidprotein3037% helix, 36% strandD0QJ68
BGII.4 norovirus CHDC2094 capsidprotein3067% helix, 36% strandD0QJ68

Ligands and binding sites

  • GLC · alpha-D-glucopyranose · sugar · 2 copies
  • GAL · beta-D-galactopyranose · sugar · 2 copies · chains B, A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, B
  • FLC · Citrate anion · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.700.9821empty
21720.650.8635empty
32490.620.8127empty
42320.600.8030empty
51720.560.8124empty

Interfaces

1 interface between chains.

  • A–B · 1883 Ų buried · 24 hydrogen bonds · protein-protein

Compared structures

  • 5IYR · Protruding domain of GII.4 human norovirus CHDC2094 in complex with 2-fucosyllactose… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.